Li J - Search Results

1

Antitumor Activity of Anti-miR-21 Delivered through Lipid Nanoparticles.

Zhang Z, Huang Y, Li J, Su F, Kuo JC, Hu Y, Zhao X, Lee RJ. Zhang Z, et al. Among authors: li j. Adv Healthc Mater. 2023 Jan;12(6):e2202412. doi: 10.1002/adhm.202202412. Epub 2022 Dec 9. Adv Healthc Mater. 2023. PMID: 36412002 Free PMC article.

2

A novel selenium analog of HDACi-based twin drug induces apoptosis and cell cycle arrest via CDC25A to improve prostate cancer therapy.

Shi Z, Liu M, Zhang X, Wang J, Zhang J, Peng Z, Meng L, Wang R, Guo L, Zhang Q, Li J, Yang L, Liu J, Xu Y, Yan J, Cui J, Ren S, Gao Y, Wang Y, Qi Z. Shi Z, et al. Among authors: li j. Theranostics. 2024 Jun 3;14(9):3565-3582. doi: 10.7150/thno.92119. eCollection 2024. Theranostics. 2024. PMID: 38948069 Free PMC article.

3

Glucosamine-Modified Reduction-Responsive Polymeric Micelles for Liver Cancer Therapy.

Meng L, Liu F, Du C, Zhu J, Xiong Q, Li J, Sun W. Meng L, et al. Among authors: li j. Molecules. 2023 Apr 30;28(9):3824. doi: 10.3390/molecules28093824. Molecules. 2023. PMID: 37175234 Free PMC article.

4

Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2.

Ao H, Song H, Li J, Wang X. Ao H, et al. Among authors: li j. Drug Deliv. 2024 Dec;31(1):2324716. doi: 10.1080/10717544.2024.2324716. Epub 2024 Mar 31. Drug Deliv. 2024. PMID: 38555735 Free PMC article.

5

Development of Drug Carriers with Biocompatibility Based On Human Serum Albumin and β-Cyclodextrin Molecules and Study of Anticancer Activity.

Yan M, Li J, Gu X, Hou X, Ma Y, Cui H, Feng C, Ma L, Wei G. Yan M, et al. Among authors: li j. Langmuir. 2022 Nov 15;38(45):13686-13696. doi: 10.1021/acs.langmuir.2c01734. Epub 2022 Oct 31. Langmuir. 2022. PMID: 36315404

6

Wu-Mei-Wan enhances brown adipose tissue function and white adipose browning in obese mice via upregulation of HSF1.

Chen S, Nie K, Wang H, Gao Y, Jiang X, Su H, Wang Z, Tang Y, Lu F, Dong H, Li J. Chen S, et al. Among authors: li j. Chin Med. 2025 Jan 3;20(1):1. doi: 10.1186/s13020-024-01053-2. Chin Med. 2025. PMID: 39754217

7

Association of pan-immune-inflammatory value with metabolic dysfunction-associated steatotic liver disease: findings from NHANES 2017-2020.

Huang LZ, Ni ZB, Yao QR, Huang WF, Li J, Wang YQ, Zhang JY. Huang LZ, et al. Among authors: li j. BMC Gastroenterol. 2025 Jan 3;25(1):4. doi: 10.1186/s12876-024-03584-2. BMC Gastroenterol. 2025. PMID: 39754093

8

RNA-binding motif protein RBM39 enhances the proliferation of gastric cancer cells by facilitating an oncogenic splicing switch in MRPL33.

Lu CP, Li JB, Li DB, Wang YH, Jiang XG, Ma JJ, Xu G. Lu CP, et al. Among authors: li jb. Acta Pharmacol Sin. 2025 Jan 3. doi: 10.1038/s41401-024-01431-4. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 39753980

9

Correction: Tea consumption and risk of bone health: an updated systematic review and meta-analysis.

Zhou F, Wang T, Li L, Yu J, Liu Z, Zhang J, Wang G, Li J, Shao C, Wang P, Chen W. Zhou F, et al. Among authors: li j. J Bone Miner Metab. 2025 Jan 3. doi: 10.1007/s00774-024-01571-x. Online ahead of print. J Bone Miner Metab. 2025. PMID: 39753928 No abstract available.

10

ABCF1-K430-Lactylation promotes HCC malignant progression via transcriptional activation of HIF1 signaling pathway.

Hong H, Han H, Wang L, Cao W, Hu M, Li J, Wang J, Yang Y, Xu X, Li G, Zhang Z, Zhang C, Xu M, Wang H, Wang Q, Yuan Y. Hong H, et al. Among authors: li j. Cell Death Differ. 2025 Jan 3. doi: 10.1038/s41418-024-01436-w. Online ahead of print. Cell Death Differ. 2025. PMID: 39753865

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193,895 results

Search Page

Filters